🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
his single-center, open-label, uncontrolled, and dose-escalation study eval...
Status
Completed
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT03773835
Treatments Being Tested
This is a Phase I, single-center, open-label, randomized,two-way crossover,...
Status
Completed
Location
West China Hospital，Sichuan University
Start Date
2019-01-09
Trial ID
NCT03745625
A double-blind, randomized, active controlled, multi-center, parallel group...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2017-12-14
Trial ID
NCT03709056
This is a Phase III, randomized, double-blind, propofol-controlled, paralle...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2018-10-09
Trial ID
NCT03674008
This is a multi-center, randomized, single-blind, propofol injectable emuls...
Status
Completed
Location
West China Hospital，Sichuan University
Start Date
2020-11-24
Trial ID
NCT04511728
This is a multi-center, randomized, open-label, positive-controlled (propof...
Status
Completed
Location
Peking University First Hospital
Start Date
2019-12-09
Trial ID
NCT04048811
Treatments Being Tested
Part 1: To determine the doses of IV HSK3486 and propofol for use in Part 2...
Status
Completed
Location
ICON (LPRA) - Salt Lake
Start Date
2022-08-16
Trial ID
NCT05614544
Efficacy and Safety of Ciprofol Sedation in Patients Undergoing Liver Cance...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-08-01
Trial ID
NCT06178926
This is a single-center, open-label, randomized, two-stage, two-way crossov...
Status
Completed
Location
the First Affilicated Hospital of Soochow University
Start Date
2019-12-14
Trial ID
NCT04145583
Treatments Being Tested
Comparison of the pharmacokinetics/Pharmacodynamics of the HSK3486 in Patie...
Status
Completed
Location
Phase I Clinical Trial Laboratory, The First Hospital of Jilin University
Start Date
2019-11-14
Trial ID
NCT04145596
Treatments Being Tested